Simmons Cancer Institute at Southern Illinois University — Springfield, Illinois

Simmons Cancer Institute at Southern Illinois University is a clinical research site located in Springfield, Illinois, United States 62702.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Simmons Cancer Institute at Southern Illinois University has participated in 4 clinical trials.

Therapeutic areas: Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Sponsors: Celgene, Rigel Pharmaceuticals, CEL-SCI Corporation.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Simmons Cancer Institute at Southern Illinois University?

Simmons Cancer Institute at Southern Illinois University has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Simmons Cancer Institute at Southern Illinois University conducted?

Simmons Cancer Institute at Southern Illinois University has 4 clinical trials on record. Their work covers Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute.

Is Simmons Cancer Institute at Southern Illinois University accredited by Crixeo Health?

Yes — Simmons Cancer Institute at Southern Illinois University holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Simmons Cancer Institute at Southern Illinois University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.